Cytosine arabinoside constant rate infusion without subsequent subcutaneous injections for the treatment of dogs with meningoencephalomyelitis of unknown origin.
Kimberley SteeBart J G BroeckxMike TargettSergio A GomesMark LowriePublished in: The Veterinary record (2020)
No clear benefit was identified in the administration of subsequent sequential CA subcutaneous injections after the first administration of CA by CRI for the treatment of dogs diagnosed with MUO.
Keyphrases